Dr. Raghib Ali
FRCP MA(cantab) MA(oxon)
Raghib Ali is a Clinical Epidemiologist in the Cancer Epidemiology Unit, an Honorary Consultant in Acute Medicine at the John Radcliffe Hospital and Director of the INDOX Cancer Research Network. His main research interests are the aetiology, prevention & treatment of non-communicable diseases in Middle Eastern and South Asian populations. He is the principal investigator for a number of clinical trials and epidemiological studies including a case-control study of colorectal cancer in India looking at the association between life-long vegetarianism and colorectal cancer in India; a prospective cohort study investigating risk factors for diabetes in the UAE and a number of studies comparing the incidence of cancer in different ethnic groups in the UK.
He graduated in Medicine from Cambridge University in 1999 where he was awarded the John Addenbrooke’s prize for Medicine and also has postgraduate degrees from the Universities of Oxford and London. He completed his clinical training in General (Internal) Medicine and Clinical Pharmacology from the Oxford Deanery in 2009.
Lifelong vegetarianism and breast cancer risk: a large multicentre case control study in India
Gathani T. et al, (2017), BMC Women's Health
Burden of Diarrhea in the Eastern Mediterranean Region, 1990-2013: Findings from the Global Burden of Disease Study 2013.
Khalil I. et al, (2016), Am J Trop Med Hyg, 95, 1319 - 1329
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.
Global Burden of Disease Cancer Collaboration None. et al, (2016), JAMA Oncol
Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015
Lim SS. et al, (2016), The Lancet, 388, 1813 - 1850
Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
Kassebaum NJ. et al, (2016), Lancet, 388, 1775 - 1812